|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.96 EUR | -0.46% |
|
-2.17% | +157.39% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | ||
| 669.22 | +15.1% | 23 | ||||||
| 200.27 | +8.58% | 22 | ||||||
| 232 | +12.18% | 19 | ||||||
| 414.83 | +33.27% | 27 | ||||||
| 256,664.68 | +46.08% | 24 | ||||||
| 263.36 | +12.21% | 18 | ||||||
| 472.33 | -10.75% | 12 | ||||||
| 71.03 | +2.49% | 14 | ||||||
| 181.81 | +5.66% | 16 | ||||||
| 138.56 | +15.66% | 6 | ||||||
| 230.93 | +1.19% | 15 | ||||||
| 70 | -2.07% | 12 | ||||||
| 67.06 | +17.14% | 16 | ||||||
| 130.53 | -2.8% | 12 | ||||||
| 124.19 | +8.82% | 21 | ||||||
| 36.41 | -9.65% | 11 | ||||||
| 610.05 | +91.59% | 19 | ||||||
| 93.1 | +70.1% | 21 | ||||||
| 51.59 | -0.75% | 17 | ||||||
| Average | 13,722.21 | +16.53% | 17 | ||||||
| Weighted average by Cap. | 20,408.29 | +16.87% | 19 |
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Sector GENFIT
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
